The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Calabrese, J. R.
* Articles by Meltzer, H. Y.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Calabrese, J. R.
* Articles by Meltzer, H. Y.
Related Collections
* Bipolar Disorder
* Tests
* Other Neuroleptics

Am J Psychiatry 1996; 153:759-764
Copyright © 1996 by American Psychiatric Association


REGULAR ARTICLES

Clozapine for treatment-refractory mania

JR Calabrese, SE Kimmel, MJ Woyshville, DJ Rapport, CJ Faust, PA Thompson and HY Meltzer
Mood Disorders Program, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

OBJECTIVE: The efficacy of clozapine for treatment-resistant mania was examined in a prospective trial for patients with bipolar or schizoaffective disorder. METHOD: The subjects were 25 acutely manic patients with either bipolar disorder (N = 10) or schizoaffective disorder-bipolar subtype (N = 15) for whom lithium, anticonvulsants, and neuroleptics had been ineffective, had produced intolerable side effects, or both. After a 7-day washout, the patients were treated with clozapine monotherapy. They were evaluated over 13 weeks with the Young Mania Rating Scale and the Brief Psychiatric Rating Scale (BPRS). RESULTS: Of the 25 patients, 18 (72%) exhibited marked improvement on the Young Mania Rating Scale, and eight (32%) exhibited marked improvement on the BPRS. The bipolar patients as compared to schizo- affective patients, and the nonrapid as compared to rapid cyclers, had significantly greater improvement in total BPRS score. CONCLUSIONS: These results suggest that clozapine is an effective therapy for treatment-resistant bipolar and schizoaffective mania.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
P. A Marken and R. W Pies
Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles
Ann. Pharmacother., February 1, 2006; 40(2): 276 - 285.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
F. T. Lewis
Bipolar Depression in Primary Care: A Hidden Threat
J Am Osteopath Assoc, June 1, 2004; 104(6_suppl): S9 - S14.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
R. A. Emsley, P. Buckley, A. M. Jones, and M. R. Greenwood
Differential Effect of Quetiapine on Depressive Symptoms in Patients with Partially Responsive Schizophrenia
J Psychopharmacol, June 1, 2003; 17(2): 210 - 215.
[Abstract] [PDF]


Home page
FocusHome page
T. Suppes, A. Webb, B. Paul, T. Carmody, H. Kraemer, and A. J. Rush
Clinical Outcome in a Randomized 1-Year Trial of Clozapine Versus Treatment as Usual for Patients With Treatment-Resistant Illness and a History of Mania
Focus, January 1, 2003; 1(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
R. M.A. Hirschfeld, C. L. Bowden, M. J. Gitlin, P. E. Keck, R. H. Perlis, T. Suppes, M. E. Thase, and K. D. Wagner
Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Focus, January 1, 2003; 1(1): 64 - 110.
[Full Text] [PDF]


Home page
BMJHome page
A H Young, K. A N Macritchie, and J R Calabrese
Treatment of bipolar affective disorder
BMJ, November 25, 2000; 321(7272): 1302 - 1303.
[Full Text]


Home page
Am. J. PsychiatryHome page
J. R. CALABRESE and P. GAJWANI
Lamotrigine and Clozapine for Bipolar Disorder
Am J Psychiatry, September 1, 2000; 157(9): 1523 - 1523.
[Full Text]


Home page
Am. J. PsychiatryHome page
A. I. Green, M. Tohen, J. K. Patel, M. Banov, C. DuRand, I. Berman, H. Chang, C. Zarate Jr., J. Posener, H. Lee, et al.
Clozapine in the Treatment of Refractory Psychotic Mania
Am J Psychiatry, June 1, 2000; 157(6): 982 - 986.
[Abstract] [Full Text]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
D. DEGNER, S. BLEICH, P. MÜLLER, G&O.;R. HAJAK, L. ADLER, and E. RÜTHER
Clozapine in the Treatment of Mania
J Neuropsychiatry Clin Neurosci, May 1, 2000; 12(2): 283 - 283.
[Full Text]


Home page
Am. J. PsychiatryHome page
T. Suppes, A. Webb, B. Paul, T. Carmody, H. Kraemer, and A. J. Rush
Clinical Outcome in a Randomized 1-Year Trial of Clozapine Versus Treatment as Usual for Patients With Treatment-Resistant Illness and a History of Mania
Am J Psychiatry, August 1, 1999; 156(8): 1164 - 1169.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
M. Tohen, T. M. Sanger, S. L. McElroy, G. D. Tollefson, K.N. R. Chengappa, D. G. Daniel, F. Petty, F. Centorrino, R. Wang, S. L. Grundy, et al.
Olanzapine Versus Placebo in the Treatment of Acute Mania
Am J Psychiatry, May 1, 1999; 156(5): 702 - 709.
[Abstract] [Full Text]


Home page
Psychiatr. Serv.Home page
D. M. Hilty, K. T. Brady, and R. E. Hales
A Review of Bipolar Disorder Among Adults
Psychiatr Serv, February 1, 1999; 50(2): 201 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. P. Freeman and A. L. Stoll
Mood Stabilizer Combinations: A Review of Safety and Efficacy
Am J Psychiatry, January 1, 1998; 155(1): 12 - 21.
[Abstract] [Full Text]


Home page
JWatch PsychiatryHome page
Clozapine: New Uses and Concerns
Journal Watch Psychiatry, August 1, 1996; 1996(801): 3 - 3.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1996 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org